Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 36
    Home » Biotech
Biotech
Biotech | 12 April 2021

Biocon receives GMP compliance certificate

The company has received a certificate of Good Manufacturing Practice compliance from the Medicines & Healthcare products Regulatory Agency (MHRA) UK

Biotech
Biotech | 30 March 2021

Biocon partners with Libbs to launch generic formulations in Brazil

Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market

Biotech
Biotech | 13 February 2021

Biocon Biologics and Viatris receive European Commission approval for Kixelle, Biosimilar Insulin Aspart

The centralized marketing authorization granted by the EC is valid in all EU Member

Biotech
Biotech | 05 February 2021

Biocon Biologics to offer its oncology biosimilars in 30+ countries

The partnership is a significant step in delivering advanced cancer therapies to patients.

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
View More

Digitization

TAKE Solutions plans AI-driven healthcare platform
TAKE Solutions plans AI-driven healthcare platform
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design
Revvity unveils AI-powered Signals Xynthetica to accelerate molecular and materials design
View More

Latest Stories

Lilly to buy Ventyx Biosciences for $1.2 billion

Amgen snaps up UK biotech Dark Blue Therapeutics in up to $840m oncology deal

Biocon Biologics unveils three new oncology biosimilars, eyes $75 billion market opportunity

GSK’s Exdensur wins Japanese nod for severe asthma

Cellenkos scores FDA orphan drug designation for CK0804 in rare blood cancer

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging
UPM unveils world’s first carbon-negative, fully recyclable black pigment
UPM unveils world’s first carbon-negative, fully recyclable black pigment
Aptar acquires Brazilian pharma packaging firm Sommaplast
Aptar acquires Brazilian pharma packaging firm Sommaplast
SOMA and Aura partner to advance innovation in on-press color correction
SOMA and Aura partner to advance innovation in on-press color correction